CRTX
Cortexyme Inc
Price:  
1.95 
USD
Volume:  
272,008.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CRTX WACC - Weighted Average Cost of Capital

The WACC of Cortexyme Inc (CRTX) is 10.3%.

The Cost of Equity of Cortexyme Inc (CRTX) is 10.30%.
The Cost of Debt of Cortexyme Inc (CRTX) is 5.00%.

Range Selected
Cost of equity 9.10% - 11.50% 10.30%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 9.1% - 11.5% 10.3%
WACC

CRTX WACC calculation

Category Low High
Long-term bond rate 4.2% 4.7%
Equity market risk premium 5.0% 6.0%
Adjusted beta 0.98 1.06
Additional risk adjustments 0.0% 0.5%
Cost of equity 9.10% 11.50%
Tax rate 26.20% 27.00%
Debt/Equity ratio 0 0
Cost of debt 5.00% 5.00%
After-tax WACC 9.1% 11.5%
Selected WACC 10.3%